Alisa P. Chernyshova, Valeriya I. Marina, Andrey G. Tereshchenkov, Vladislava E. Sagitova, Maksim A. Kryakvin, Nikolai D. Dagaev, E.G. Yurchenko, Kseniya A. Arzamazova, Elena B. Guglya, Olga A. Belozerova, Sergey I. Kovalchuk, Margarita N. Baranova, Arsen M. Kudzhaev, Anton E. Shikov, Maria N. Romanenko, A. Yu. Rudenko, Vladimir K. Chebotar, Maria S. Gancheva, Maria E. Baganova, Mikhail V. Biryukov, Tatiana V. Panova, Maria G. Khrenova, Vadim N. Tashlitsky, Natalia V. Sumbatyan, Yuliya V. Zakalyukina, Kirill S. Antonets, Anton A. Nizhnikov, Vladimir I. Polshakov, Stanislav S. Terekhov, Maria I. Zvereva, O. Dontsova, Петр В. Сергиев, Vera A. Alferova, Dmitrii A. Lukianov
Oxydifficidin is a natural polyketide antibiotic that has long been recognized as a ribosome-targeting agent that inhibits protein synthesis. In this paper, we describe Bacillus velezensis strain EV17 and compare its complete genome sequence with that of the previously characterized B. velezensis strain K-3618 and the difficidin biosynthetic gene cluster (BGC) combined with mass spectrometry to elucidate the production of oxydifficidin by these strains. Toeprinting and small fluorescent peptide assays showed that isolated oxydifficidin induces a generalized inhibition of translation at every step of elongation in protein biosynthesis. In previous studies, it has been demonstrated that oxydifficidin targets bL12 protein. Although spontaneous mutations conferring resistance to oxydifficidin in ribosomal protein bL12 located relatively close to the thiostrepton binding site on uL11, our data show that oxydifficidin binding does not interfere with thiostrepton, thereby refining previous findings about its putative ribosomal target. We are the first to show that this compound does not affect eukaryotic translation and has two orders of magnitude lower effect on eukaryotic cells compared to bacteria. These facts are important to further investigate its potential as a bioprotectant against phytopathogens or even as a therapeutic agent.